[23] In the diseased brain, GLP-1 receptor agonist treatment is associated with protection against a range of experimental disease models such as Parkinson's disease, [24] [18] Alzheimer's disease, [25] [26] stroke, [24] traumatic brain injury, [14] [19] and multiple sclerosis
Of the 3 subtypes of JNK, JNK1 and JNK2 are most relevant to our interest, and they will be collectively referred to as JNK
Dihexa targets a persons cognitive function specifically and produces chemicals that the brain requires to enhance memory
Research models frequently examine BPC-157 for its interactions with growth factor pathways, nitric oxide signaling, and cytoprotective mechanisms at the cellular level
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
Alcohol, sugar, fat, misuse of medications, toxins, and pollutants can cause stress to your liver